Chonnam Med J.  2014 Aug;50(2):63-66. 10.4068/cmj.2014.50.2.63.

Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency

• Kim SA
• Choe YR
• Yang EM
• Kim CJ

• KMID: 2172161
• DOI: http://doi.org/10.4068/cmj.2014.50.2.63

Abstract

After recombinant human growth hormone (rhGH) was introduced in the treatment of patients with growth hormone deficiency (GHD) and idiopathic short stature (ISS), many studies have addressed the effect of GH treatment and changes in the height standard deviation score (SDS) after GH treatment. However, few studies comparing the effect of GH in Korean patients with idiopathic GHD and ISS have been designed. Therefore, this study focused on the difference in effect of GH treatment between the two groups. We retrospectively reviewed the height SDS of 34 patients with idiopathic GHD and 12 patients with ISS. The mean ages of the patients with idiopathic GHD and ISS were 9.84+/-2.09 and 10.72+/-1.48 years, respectively. All patients were treated with GH for 1 year and body parameters were recorded before and after the GH treatment. Change in height SDS in patients with idiopathic GHD was significantly higher than that in patients with ISS (0.62+/-0.33 vs. 0.40+/-0.27, p=0.03). However, body mass index, insulin-like growth factor-1, and insulin-like growth factor binding protein-3 were not significantly different between the two groups after GH treatment. These results suggest that GH treatment has a more powerful effect on increasing height SDS in patients with idiopathic GHD than in patients with ISS.

Keyword

Growth hormone; Idiopathic short stature; Deficiency

MeSH Terms

Body Mass Index
Growth Hormone*
Human Growth Hormone
Humans
Retrospective Studies
Growth Hormone
Human Growth Hormone

Reference

1. Cook DM, Rose SR. A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary. 2012; 15:301–310.

2. Grumbach MM, Bin-Abbas BS, Kaplan SL. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res. 1998; 49:Suppl 2. 41–57.

3. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab. 2000; 85:3990–3993.

4. Moore KC, Donaldson DL, Ideus PL, Gifford RA, Moore WV. Clinical diagnoses of children with extremely short stature and their response to growth hormone. J Pediatr. 1993; 122:687–692.

5. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A. The Genentech Growth Study Group. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab. 1997; 82:418–420.

6. Choi IJ, Hwang JS, Shin CH, Yang SW. Factors affecting on final adult height and total height gain in children with idiopathic and organic growth hormone deficiency after growth hormone treatment. J Korean Pediatr Soc. 2003; 46:803–810.

7. Shin CH. Current use of growth hormone in children. Korean J Pediatr. 2006; 49:703–709.

8. Lee KH. Growth hormone therapy in short stature children. J Korean Med Assoc. 2008; 51:849–855.

9. Kang JC, Choi YS, Choi IK, Kim HS, Kim DH. The effect of growth hormone on patients with growth hormone deficiency and idiopathic short stature. Korean J Pediatr. 2004; 47:310–318.

10. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press;1959.

11. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab. 1958; 18:901–903.

12. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, et al. National Institute of Child Health and Human Development-Eli Lilly & Co. Growth Hormone Collaborative Group. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004; 89:3140–3148.

13. Murray RD, Brennan BM, Rahim A, Shalet SM. Survivors of childhood cancer: long-term endocrine and metabolic problems dwarf the growth disturbance. Acta Paediatr Suppl. 1999; 88:5–12.

14. Wit JM, Rekers-Mombarg LT. Dutch Growth Hormone Advisory Group. Final height gain by GH therapy in children with idiopathic short stature is dose dependent. J Clin Endocrinol Metab. 2002; 87:604–611.

15. Lechuga-Sancho A, Lechuga-Campoy JL, del Valle-Núñez J, Rivas-Crespo F. Predicting the growth response of children with idiopathic growth hormone deficiency to one year of recombinant growth hormone treatment: derivation and validation of a useful method. J Pediatr Endocrinol Metab. 2009; 22:501–509.

16. Saenger P. Partial growth hormone insensitivity--idiopathic short stature is not always idiopathic. Acta Paediatr Suppl. 1999; 88:194–198.

17. Marchini A, Marttila T, Winter A, Caldeira S, Malanchi I, Blaschke RJ, et al. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem. 2004; 279:37103–37114.

18. Kim DH, Shin HJ, Chung SC, Park MJ. Response of growth hormone treatment to final height in children with growth hormone deficiency and familial short stature. J Korean Soc Pediatr Endocrinol. 1999; 4:159–169.

19. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, et al. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr. 1994; 125:196–200.

20. Kawai M, Momoi T, Yorifuji T, Yamanaka C, Sasaki H, Furusho K. Unfavorable effects of growth hormone therapy on the final height of boys with short stature not caused by growth hormone deficiency. J Pediatr. 1997; 130:205–209.

21. Hindmarsh PC, Brook CG. Final height of short normal children treated with growth hormone. Lancet. 1996; 348:13–16.

22. McCaughey ES, Mulligan J, Voss LD, Betts PR. Randomised trial of growth hormone in short normal girls. Lancet. 1998; 351:940–944.

23. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH. Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab. 1998; 83:1075–1079.

24. Hintz RL, Attie KM, Baptista J, Roche A. Genentech Collaborative Group. Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med. 1999; 340:502–507.

25. Kamp GA, Wit JM. High-dose growth hormone therapy in idiopathic short stature. Horm Res. 1998; 49:Suppl 2. 67–72.

26. Hintz RL. Growth hormone treatment of idiopathic short stature. Horm Res. 1996; 46:208–214.

27. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med. 2002; 156:230–240.